CVS Health降低了Q3收入前景,任命David Joyner为新的首席执行官。 CVS Health lowers Q3 earnings outlook, appoints David Joyner as new CEO.

美国CVS健康公司在下调第三季度财报预期并宣布任命David Joyner为新的总裁兼首席执行官后, 在市场前交易中下跌. CVS Health Corporation's stock fell in pre-market trading after it lowered its third-quarter earnings outlook and announced the appointment of David Joyner as the new president and CEO, succeeding Karen Lynch. 调整后的每股收入预测为1.05-1.10美元,大大削减了华尔街1.69美元的估计数。 The adjusted earnings per share forecast (EPS) of $1.05-$1.10 significantly undercuts Wall Street's $1.69 estimate. 公司在第二季度曾报告强的收益,但收入低于预期. The company previously reported strong earnings in Q2, but revenue was below expectations.